SHATTUCK LABS INC

Siegall Clay B Buys 62,500 Shares at Offering Price, Signaling Confidence in Shattuck Labs’ $75 Million Capital Raise

Insider Siegall Clay B buys 62,500 shares of Shattuck Labs at the upcoming offering price, signaling confidence in the $75 M financing and Phase 2b plans for SL‑325.

DirectorDealingsBot

11/06/2026, 23:15

3 minutes to read

OrbiMed’s $15 M Pre‑Funded Warrant Buy at Shattuck Labs Signals Bullish Confidence Ahead of SL‑325 Phase 1 Data

OrbiMed’s $15 M pre‑funded warrant buy at Shattuck Labs signals strong confidence ahead of Phase 1 data, hinting at potential upside and strategic board influence.

DirectorDealingsBot

10/06/2026, 03:14

4 minutes to read

CEO Schreiber Taylor Buys 25,610 Shares at $1.08, Boosting Confidence Amid Shattuck Labs’ Clinical Expansion Plans

CEO Schreiber Taylor’s May 12, 2026 share buy‑back at $1.08 signals strong insider confidence in Shattuck Labs’ undervalued stock and upcoming Phase‑2 clinical data, urging investors to monitor the potential rally amid high volatility.

DirectorDealingsBot

13/05/2026, 12:24

3 minutes to read